Polycystic ovary syndrome update in adolescence
Explore this paper's citation graph
Summary
An increasing number of adolescents are presenting with signs of polycystic ovary syndrome, and efforts should be made to diagnose and treat these women in adolescence to minimize the development of symptoms, and prevent the onset of cardiovascular and metabolic problems.
- Type
- article
- Published
- 2007-08-01
- Cited by
- 45
- References
- 56
- Access
- Open access
- OpenAlex
- https://openalex.org/W17630601
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:36027418
Keywords
Computer science
References
- Menstrual disorders in adolescents. Excess androgens and the polycystic ovary syndrome.
- Use of insulin sensitizers in polycystic ovarian syndrome.
- Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome
- Polycystic ovary syndrome in adolescence. New insights in pathophysiology and treatment.
- Polycystic Ovary Syndrome in Adolescents
- Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
- Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
- Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.
- Treatment of hirsutism and acne in hyperandrogenism.
- Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline.
- Puberty and polycystic ovary syndrome.
- Role of diet in the treatment of polycystic ovary syndrome.
- Prevention of diabetes and cardiovascular disease in women with PCOS: treatment with insulin sensitizers.
- Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
- Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.
- Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome.
- Evaluation of a type 2 diabetes screening protocol in an urban pediatric clinic.
- Role of lifestyle modification in the management of polycystic ovary syndrome.
- Spironolactone in the treatment of polycystic ovary syndrome: Effects on clinical features, insulin sensitivity and lipid profile
- Polycystic Ovarian Syndrome: An Evidence-based Approach to Evaluation and Management of Diabetes and Cardiovascular Risks for Today's Clinician
Cited by
- Practitioner’s Perspective on Barriers to Diagnosing Polycystic Ovarian Syndrome in Adolescents: A Descriptive Study
- Ovarian reserve in women of late reproductive age by the method of treatment of PCOS
- Evaluation of Adolescents for Polycystic Ovary Syndrome in an Urban Population
- Young women's experiences living with polycystic ovary syndrome.
- Features of Polycystic Ovary Syndrome in adolescence
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Reflections on Future Research in Adolescent Reproductive Health
- Insulin Resistance, Obesity, Hypofibrinolysis, Hyperandrogenism, and Coronary Heart Disease Risk Factors in 25 Pre-Perimenarchal Girls Age <14 Years, 13 with Precocious Puberty, 23 with a First-degree Relative with Polycystic Ovary Syndrome
- [Clinical manifestations, biochemical, ultrasonographic and metabolic of polycystic ovary syndrome in adolescents].
- Menstruation in Adolescents
- Diagnosis of adolescent polycystic ovary syndrome.
- CYP1A1 polymorphism in adolescents with polycystic ovary syndrome
- Dysfunctional uterine bleeding in adolescent females associated with endocrine causes and medical conditions.
- Emotional needs of teens with polycystic ovary syndrome.
- Polycystic ovary syndrome in adolescents.
- Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period
- Polycystic ovarian syndrome in adolescence
- Whither PCOS? The challenges of establishing hyperandrogenism in adolescent girls.
- Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk.
- A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome.
Related papers
- The Economic Future of Nuclear Power
- Nuclear engineering education: a critical review
- Conventional curricula versus the contemporary nuclear engineering experience
- Education programs in nuclear engineering departments at Japanese universities
- Contribution of French universities to training developing country personnel in nuclear science